Characterization and in vitro testing of newly isolated lytic bacteriophages for the biocontrol of Pseudomonas aeruginosa

References

• 1. Prestinaci F, Pezzotti P, Pantosti A. Antimicrobial resistance: a global multifaceted phenomenon. Pathog. Glob. Health 109(7), 309–318 (2015).
  MedlineGoogle Scholar
• 2. Ferri M, Ranucci E, Romagnoli P, Giaccone V. Antimicrobial resistance: a global emerging threat to public health systems. Crit. Rev. Food Sci. Nutr. 57(13), 2857–2876 (2017).
  Medline CASGoogle Scholar
• 3. Naylor NR, Atun R, Zhu N et al. Estimating the burden of antimicrobial resistance: a systematic literature review. Antimicrob. Resist. Infect. Control 7, 58 (2018).
  MedlineGoogle Scholar
• 4. Tacconelli E, Magrini N, Carmeli Y et al. Global priority list of antibiotic-resistant bacteria to guide research, discovery, and development of new antibiotics. World Health Organ. 1–7 (2017).
  Google Scholar
• 5. Pires DP, Boas DV, Sillankorva S, Azeredo J. Phage therapy: a step forward in the treatment of Pseudomonas aeruginosa infections. J. Virol. 89, 7449–7566 (2015).
  Medline CASGoogle Scholar
• 6. CDC. Antibiotic resistance threats in the United States. GA, USA www.cdc.gov/drugresistance/pdf/threats–report/2019–ar–threats–report–508.pdf
  Google Scholar
• 7. Kerr K, Senelling A. Pseudomonas aeruginosa: a formidable and ever-present adversary. J. Hosp. Infect. 73, 338–344 (2009).
  Medline CASGoogle Scholar
• 8. Pachori P, Gothalwal R, Gandhi P. Emergence of antibiotic resistance Pseudomonas aeruginosa in intensive care unit: a critical review. Genes Dis. 6(2), 109–119 (2019).
  MedlineGoogle Scholar
• 9. Poole K. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria. Curr. Pharm. Biotechnol. 3, 77–98 (2002).
  Medline CASGoogle Scholar
• 10. Wagner V, Filiatrault M, Picardo K, Iglewski B, Cornelis P. Pseudomonas: genomics and molecular biology. Caister Academic Press, Norfolk, UK, (2008).
  Google Scholar
• 11. Fajardo A, Martínez-Martín N, Mercadillo M et al. The neglected intrinsic resistome of bacterial pathogens. PLoS One. 3, e1619 (2008).
  MedlineGoogle Scholar
• 12. Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa – mechanisms, epidemiology and evolution. Drug Resist. Updat. 44, 26–47 (2019).
  Google Scholar
• 13. Breidenstein EB, de la Fuente-Núñez C, Hancock RE. Pseudomonas aeruginosa: all roads lead to resistance. Trends Microbiol. 19, 419–426 (2011).
  Medline CASGoogle Scholar
• 14. Lopes A, Pereira C, Almeida A. Sequential combined effect of phages and antibiotics on the inactivation of E. coli. Microorganisms 6(125), 2–20 (2018).
  Google Scholar
• 15. Dorotkiewicz–Jach A, Augustyniak D, Olszak T, Drulis-Kawa Z. Modern therapeutic approaches against Pseudomonas aeruginosa infections. Curr. Med. Chem. 22(14), 1642–1664 (2015).
  Medline CASGoogle Scholar
• 16. Chan BK, Abedon ST, Loc-Carrillo C. Phage cocktails and the future of phage therapy. Future Microbiol. 8(6), 769–783 (2013).
  CASGoogle Scholar
• 17. Haq IU, Chaudhry WN, Akhtar MN, Andleeb S, Qadri I. Bacteriophages and their implications on future biotechnology: a review. Virol. J. 9(1), 2–8 (2012).
  MedlineGoogle Scholar
• 18. Górski A, Międzybrodzki R, Węgrzyn G, Jończyk-Matysiak E, Borysowski J, Weber-Dąbrowska B. Phage therapy: current status and perspectives. Med. Res. Rev. 40(1), 459–463 (2020).
  MedlineGoogle Scholar
• 19. Kortright KE, Chan BK, Koff JL, Turner PE. Phage therapy: a renewed approach to combat antibiotic-resistant bacteria. Cell Host Microbe 25(2), 219–232 (2019).
  Medline CASGoogle Scholar
• 20. Rios AC, Moutinho CG, Pinto FC et al. Alternatives to overcoming bacterial resistances: state-of-the-art. Microbiol. Res. 191, 51–80 (2016).
  Medline CASGoogle Scholar
• 21. Harada LK, Silva EC, Campos WF et al. Biotechnological applications of bacteriophages: state of the art. Microbiol. Res. 212–213, 38–58 (2018).
  Medline CASGoogle Scholar
• 22. Almeida A, Cunha Â, Gomes NCM, Alves E, Costa L, Faustino MAF. Phage therapy and photodynamic therapy: low environmental impact approaches to inactivate microorganisms in fish farming plants. Mar. Drugs 7(3), 268–313 (2009).
  Medline CASGoogle Scholar
• 23. Beeton ML, Alves DR, Enright MC, Jenkins ATA. Assessing phage therapy against Pseudomonas aeruginosa using a Galleria mellonella infection model. Int. J. Antimicrob. Agents 46(2), 196–200 (2015).
  Medline CASGoogle Scholar
• 24. Debarbieux L, Leduc D, Maura D et al. Bacteriophages can treat and prevent Pseudomonas aeruginosa lung infections. J. Infect. Dis. 201(7), 1096–1104 (2010).
  Medline CASGoogle Scholar
• 25. Forti F, Roach DR, Cafora M et al. Design of a broad-range bacteriophage cocktail that reduces Pseudomonas aeruginosa biofilms and treats acute infections in two animal models. Antimicrob. Agents Chemother. 62(6), e02573–17 (2018).
  Medline CASGoogle Scholar
• 26. Chegini Z, Khoshbayan A, Moghadam MT, Farahani I, Jazireian P, Shariati A. Bacteriophage therapy against Pseudomonas aeruginosa biofilms: a review. Ann. Clin. Microbiol. Antimicrob. 19, 45 (2020).
  MedlineGoogle Scholar
• 27. Alvi IA, Asif M, Tabassum R, Aslam R, Abbas Z, Rehman SU. RLP, a bacteriophage of the family Podoviridae, rescues mice from bacteremia caused by multi-drug-resistant Pseudomonas aeruginosa. Arch. Virol. 165, 1289–1297 (2020).
  Medline CASGoogle Scholar
• 28. Ceyssens PJ, Lavigne R. Bacteriophages of Pseudomonas. Future Microbiol. 5(7), 1041–1055 (2010).
  Google Scholar
• 29. Danis-Wlodarczyk K, Olszak T, Arabski M et al. Characterization of the newly isolated lytic bacteriophages KTN6 and KT28 and their efficacy against Pseudomonas aeruginosa biofilm. PLoS ONE 10(5), e0127603 (2015).
  MedlineGoogle Scholar
• 30. Duplessis C, Biswas B, Hanisch B et al. Refractory Pseudomonas bacteremia in a 2-year-old sterilized by bacteriophage therapy. J. Pediatric Infect. Dis. Soc. 7, 253–256 (2017).
  Google Scholar
• 31. Jault P, Leclerc T, Jennes S et al. Efficacy and tolerability of a cocktail of bacteriophages to treat burn wounds infected by Pseudomonas aeruginosa (PhagoBurn): a randomised, controlled, double-blind phase 1/2 trial. Lancet Infect. Dis. 19, 35–45 (2019).
  MedlineGoogle Scholar
• 32. Hyman P, Abedon ST. Bacteriophage host range and bacterial resistance. Adv. Appl. Microbiol. 70, 217–248 (2010).
  Medline CASGoogle Scholar
• 33. Chaturongakul S, Ounjai P. Phage–host interplay: examples from tailed phages and Gram-negative bacterial pathogens. Front. Microbiol. 5, 442 (2014).
  MedlineGoogle Scholar
• 34. Adams MH. Bacteriophages. Adams MH (Ed.). Interscience Publishers, Inc., London, UK, 592 (1959).
  Google Scholar
• 35. Rios AC, Vila MMDC, Lima R et al. Structural and functional stabilization of bacteriophage particles within the aqueous core of a W/O/W multiple emulsion: a potential biotherapeutic system for the inhalational treatment of bacterial pneumonia. Process Biochem. 64(September 2017), 177–192 (2018).
  CASGoogle Scholar
• 36. Silva EC, Oliveira TJ, Moreli FC, Harada LK, Vila MMDC, Balcão VM. Newly isolated lytic bacteriophages for Staphylococcus intermedius, structurally and functionally stabilized in a hydroxyethylcellulose gel containing choline geranate: potential for transdermal permeation in veterinary phage therapy. Res. Vet. Sci. 135, 42–58 (2021).
  Medline CASGoogle Scholar
• 37. Scherrer P. Bestimmung der Größe und der inneren Struktur von Kolloidteilchen mittels Röntgenstrahlen. Nachrichten von der Gesellschaft der Wissenschaften zu Göttingen. 26(98–100), (1918).
  Google Scholar
• 38. Pereira C, Moreirinha C, Lewicka M et al. Bacteriophages with potential to inactivate Salmonella typhimurium: Use of single phage suspensions and phage cocktails. Virus Res. 220, 179–192 (2016).
  Medline CASGoogle Scholar
• 39. Pinheiro LAM, Pereira C, Barreal ME, Gallego PP, Balcão VM, Almeida A. Use of phage ϕ6 to inactivate Pseudomonas syringae pv. actinidiae in kiwifruit plants: in vitro and ex vivo experiments. Appl. Microbiol. Biotechnol. 104(3), 1319–1330 (2020).
  Medline CASGoogle Scholar
• 40. Melo LDR, Sillankorva S, Ackermann H–W, Kropinski AM, Azeredo J, Cerca N. Isolation and characterization of a new Staphylococcus epidermidis broad-spectrum bacteriophage. J. Gen. Virol. 95, 506–515 (2014).
  Medline CASGoogle Scholar
• 41. Pinheiro LAM, Pereira C, Frazão C, Balcão VM, Almeida A. Efficiency of phage ϕ6 for biocontrol of Pseudomonas syringae pv. syringae: an in vitro preliminary study. Microorganisms 7(9), 286 (2019).
  CASGoogle Scholar
• 42. Pinheiro LAM, Pereira C, Barreal ME, Gallego PP, Balcão VM, Almeida A. Use of phage ϕ6 to inactivate Pseudomonas syringae pv. actinidiae in kiwifruit plants: in vitro and ex vivo experiments. Appl. Microbiol. Biotechnol. 104(3), 1319–1330 (2019).
  MedlineGoogle Scholar
• 43. Stuer-Lauridsen B, Janzen T, Schnabl J, Johansen E. Identification of the host determinant of two prolate-headed phages infecting Lactococcus lactis. Virology 309(1), 10–17 (2003).
  Medline CASGoogle Scholar
• 44. Shao Y, Wang I-N. Bacteriophage adsorption rate and optimal lysis time. Genetics 180(1), 471–482 (2008).
  MedlineGoogle Scholar
• 45. Santos SB, Carvalho C, Azeredo J, Ferreira EC. Population dynamics of a Salmonella lytic phage and its host: implications of the host bacterial growth rate in modelling. PLoS ONE 9(7), e102507 (2014).
  MedlineGoogle Scholar
• 46. García R, Latz S, Romero J, Higuera G, García K, Bastías R. Bacteriophage production models: an overview. Front. Microbiol. 10(June), 1–7 (2019).
  MedlineGoogle Scholar
• 47. Chen S, Zhou Y, Chen Y, Gu J. fastp: an ultra-fast all-in-one FASTQ preprocessor. Bioinformatics 34(17), i884–i890 (2018).
  MedlineGoogle Scholar
• 48. Bankevich A, Nurk S, Antipov D et al. SPAdes: a new genome assembly algorithm and its applications to single-cell sequencing. J. Comput. Biol. 19(5), 455–477 (2012).
  Medline CASGoogle Scholar
• 49. Tritt A, Eisen JA, Facciotti MT, Darling AE. An integrated pipeline for de novo assembly of microbial genomes. PLoS ONE 7(9), e42304 (2012).
  Medline CASGoogle Scholar
• 50. Zimin AV, Marçais G, Puiu D, Roberts M, Salzberg SL, Yorke JA. The MaSuRCA genome assembler. Bioinformatics 29(21), 2669–2677 (2013).
  Medline CASGoogle Scholar
• 51. Hunt M, Gall A, Ong SH et al. IVA: accurate de novo assembly of RNA virus genomes. Bioinformatics 31(14), 2374–2376 (2015).
  Medline CASGoogle Scholar
• 52. Gurevich A, Saveliev V, Vyahhi N, Tesler G. QUAST: quality assessment tool for genome assemblies. Bioinformatics 29(8), 1072–1075 (2013).
  Medline CASGoogle Scholar
• 53. Wences AH, Schatz MC. Metassembler: merging and optimizing de novo genome assemblies. Genome Biol. 16, 207 (2015).
  MedlineGoogle Scholar
• 54. Langmead B, Salzberg S. Fast gapped-read alignment with Bowtie 2. Nat. Methods 9, 357–359 (2012).
  Medline CASGoogle Scholar
• 55. Zhou CLE, Kimbrel J, Edwards R, McNair K, Souza BA, Malfatti S. MultiPhATE2: code for functional annotation and comparison of bacteriophage genomes. doi: https://doi.org/10.1101/2020.10.05.324566 bioRxiv (2020).
  Google Scholar
• 56. Grazziotin AL, Koonin EV, Kristensen DM. Prokaryotic virus orthologous groups (pVOGs): a resource for comparative genomics and protein family annotation. Nucleic Acids Res. 45(D1), D491–D498 (2017).
  Medline CASGoogle Scholar
• 57. Brister JR, Ako-adjei D, Bao Y, Blinkova O. NCBI viral genomes resource. Nucleic Acids Res. 43(D1), D571–D577 (2015).
  Medline CASGoogle Scholar
• 58. Overbeek R, Olson R, Pusch GD et al. The SEED and the rapid annotation of microbial genomes using subsystems technology (RAST). Nucleic Acids Res. 42(D1), D206–D214 (2014).
  Medline CASGoogle Scholar
• 59. Bolduc B, Jang HB, Doulcier G, You Z-Q, Roux S, Sullivan MB. vConTACT: an iVirus tool to classify double-stranded DNA viruses that infect archaea and bacteria. PeerJ. 5, e3243 (2017).
  MedlineGoogle Scholar
• 60. Li W, Godzik A. CD-HIT: a fast program for clustering and comparing large sets of protein or nucleotide sequences. Bioinformatics 22(13), 1658–1659 (2006).
  Medline CASGoogle Scholar
• 61. Katoh K, Rozewicki J, Yamada KD. MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization. Br. Bioinform. 20(4), 1160–1166 (2019).
  Medline CASGoogle Scholar
• 62. Price MN, Dehal PS, Arkin AP. FastTree: computing large minimum evolution trees with profiles instead of a distance matrix. Mol. Biol. Evol. 26(7), 1641–1650 (2009).
  Medline CASGoogle Scholar
• 63. Zhou T, Yang L, Lu Y et al. DNAshape: a method for the high-throughput prediction of DNA structural features on a genomic scale. Nucleic Acids Res. 41, W56–W62 (2013).
  MedlineGoogle Scholar
• 64. Pires DP, Oliveira H, Melo LDR, Sillankorva S, Azeredo J. Bacteriophage-encoded depolymerases: their diversity and biotechnological applications. Appl. Microbiol. Biotechnol. 100(5), 2141–2151 (2016).
  Medline CASGoogle Scholar
• 65. Oliveira H, São-José C, Azeredo J. Phage-derived peptidoglycan degrading enzymes: challenges and future prospects for in vivo therapy. Viruses 10(6), 292 (2018).
  Google Scholar
• 66. Hyman P. Phages for phage therapy: isolation, characterization and host range breadth. Pharmaceuticals 12, 35 (2019).
  CASGoogle Scholar
• 67. Mbonyiryivuze A, Omollo I, Ngom BD et al. Natural dye sensitizer for Grätzel cells: Sepia melanin. Phys. Mater. Chem. 3(1), 1–6 (2015).
  CASGoogle Scholar
• 68. Pereira C, Moreirinha C, Lewicka M et al. Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli. Virus Res. 227, 171–182 (2017).
  Medline CASGoogle Scholar
• 69. Hawkins C, Harper D, Burch D, Anggard E, Soothill J. Topical treatment of Pseudomonas aeruginosa otitis of dogs with a bacteriophage mixture: a before/after clinical trial. Vet. Microbiol. 146, 309–313 (2010).
  MedlineGoogle Scholar
• 70. Meaden S, Koskella B. Exploring the risks of phage application in the environment. Front. Microbiol. 4, 358 (2013).
  MedlineGoogle Scholar
• 71. Abedon ST. Lysis from without. Bacteriophage 1(1), 46–49 (2011).
  MedlineGoogle Scholar
• 72. Ross A, Ward S, Hyman P. More is better: selecting for broad host range bacteriophages. Front. Microbiol. 7, 1352 (2016).
  MedlineGoogle Scholar
• 73. Kutter E. Phage host range and efficiency of plating. In: Bacteriophage: Methods and protocols. Clokie MRKropinski AM (Ed.). Humana Press, 141–149 (2009).
  Google Scholar
• 74. Seed KD. Battling phages: how bacteria defend against viral attack. PLOS Pathog. 11, e1004847 (2015).
  MedlineGoogle Scholar
• 75. Speyer JF, Khairallah LH. Crystalline T4 bacteriophage. J. Mol. Biol. 76(3), 415–417 (1973).
  Medline CASGoogle Scholar
• 76. Fischer C, Yoichi M, Unno H, Tanji Y. The coexistence of Escherichia coli serotype O157:H7 and its specific bacteriophage in continuous culture. FEMS Microbiol. Lett. 241, 171–177 (2004).
  Medline CASGoogle Scholar
• 77. Cao Z, Zhang J, Niu YD et al. Isolation and characterization of a “phiKMV–like” bacteriophage and its therapeutic effect on mink hemorrhagic pneumonia. PLoS One 10(1), e0116571 (2015).
  MedlineGoogle Scholar
• 78. Abedon S, Culler RR. Optimizing bacteriophage plaque fecundity. J. Theor. Biol. 249, 582–592 (2007).
  Medline CASGoogle Scholar
• 79. Mateus L, Costa L, Silva YJ, Pereira C, Cunha A, Almeida A. Efficiency of phage cocktails in the inactivation of Vibrio in aquaculture. Aquaculture 424–425, 167–173 (2014).
  Google Scholar
• 80. Bull JJ, Gill JJ. The habits of highly effective phages: population dynamics as a framework for identifying therapeutic phages. Front. Microbiol. 5, 1–12 (2014).
  MedlineGoogle Scholar
• 81. Drulis–Kawa Z, Majkowska–Skrobek G, Maciejewska B, Delattre A–S, Lavigne R. Learning from bacteriophages – advantages and limitations of phage and phage-encoded protein applications. Curr. Protein Pept. Sci. 13(8), 699–722 (2012).
  Medline CASGoogle Scholar
• 82. Jin J, Li ZJ, Wang S-W et al. Isolation and characterization of ZZ1, a novel lytic phage that infects Acinetobacter baumannii clinical isolates. BMC Microbiol. 12, 156 (2012).
  Medline CASGoogle Scholar
• 83. Ceyssens P-J. Isolation and characterization of lytic bacteriophages infecting Pseudomonas aeruginosa. ISBN 978–90–8826–123–7 (2009).
  Google Scholar
• 84. Hyman P, Abedon ST. Practical methods for determining phage growth parameters. In: Bacteriophages: methods and protocols, volume 1: isolation, characterization, and interactions. Clokie MRJKropinski AM (Eds). Humana Press, 175–202 (2009).
  Google Scholar
• 85. Moldovan R, Chapman-McQuiston E, Wu XL. On kinetics of phage adsorption. Biophys. J. 93(1), 303–315 (2007).
  Medline CASGoogle Scholar
• 86. Storms ZJ, Sauvageau D. Modeling tailed bacteriophage adsorption: insight into mechanisms. Virology 485, 355–362 (2015).
  Medline CASGoogle Scholar
• 87. Rakhuba DV, Kolomiets EI, Szwajcer Dey E, Novik GI. Bacteriophage receptors, mechanisms of phage adsorption and penetration into host cell. Polish J. Microbiol. 59(3), 145–155 (2010).
  Medline CASGoogle Scholar
• 88. Lindberg HM, McKean KA, Wang I–N. Phage fitness may help predict phage therapy efficacy. Bacteriophage 4(4), e964081 (2014).
  MedlineGoogle Scholar
• 89. Shephard J, McQuillan AJ, Bremer PJ. Mechanisms of cation exchange by Pseudomonas aeruginosa PAO1 and PAO1 wbpL, a strain with a truncated lipopolysaccharide. Appl. Environ. Microbiol. 74(22), 6980–6986 (2008).
  Medline CASGoogle Scholar
• 90. Marcus IM, Herzberg M, Walker SL, Freger V. Pseudomonas aeruginosa attachment on QCM-D sensors: the role of cell and surface hydrophobicities. Langmuir 28(15), 6396–6402 (2012).
  Medline CASGoogle Scholar
• 91. Esteban PP, Jenkins ATA, Arnot TC. Elucidation of the mechanisms of action of bacteriophage K/nano-emulsion formulations against S. aureus via measurement of particle size and zeta potential. Colloids Surfaces B Biointerfaces 139, 87–94 (2016).
  Medline CASGoogle Scholar
• 92. Kőnig-Péter A, Kilár F, Pernyeszi T. Copper(II) biosorption characteristics of lyophilized and thermally treated Pseudomonas cells. Environ. Eng. Manag. J. 18(2), 455–464 (2019).
  CASGoogle Scholar
• 93. Choi N, Bae Y, Lee S. Cell surface properties and biofilm formation of pathogenic bacteria. Food Sci. Biotechnol. 24, 2257–2264 (2015).
  CASGoogle Scholar
• 94. Zemb O, Manefield M, Thomas F, Jacquet S. Phage adsorption to bacteria in the light of the electrostatics: a case study using E. coli, T2 and flow cytometry. J. Virol. Methods 189(2), 283–289 (2013).
  Medline CASGoogle Scholar
• 95. Glasser CA, Vila MMDC, Pereira JC et al. Development of a water-in-oil-in-water multiple emulsion system integrating biomimetic aqueous-core lipid nanodroplets for protein entity stabilization. Part II: process and product characterization. Drug Dev. Ind. Pharm. 42(12), 1990–2000 (2016).
  Medline CASGoogle Scholar
• 96. Katayama K, Nomura H, Ogata H, Eitoku T. Diffusion coefficients for nanoparticles under flow and stop–flow conditions. Phys. Chem. Chem. Phys. 11, 10494–10499 (2009).
  Medline CASGoogle Scholar
• 97. Derjaguin BV, Churaev NV, Muller VM. The Derjaguin-Landau-Verwey-Overbeek (DLVO) theory of stability of lyophobic colloids. In: Surface Forces Springer, MA, USA, 293–310 (1987).
  Google Scholar
• 98. Wang H, Newby B-MZ. Applicability of the extended Derjaguin-Landau-Verwey-Overbeek theory on the adsorption of bovine serum albumin on solid surfaces. Biointerphases. 9(4), 041006–1–041006–8 (2014).
  Google Scholar
• 99. ChiHsin H, ChongYi L, JongKang L, ChanShing L. Control of the eel (Anguilla japonica) pathogens, Aeromonas hydrophila and Edwardsiella tarda, by bacteriophages. J. Fish. Soc. Taiwan. 27(1), 21–31 (2000).
  Google Scholar
• 100. Pasharawipas T, Manopvisetcharean J, Flegel T. Phage treatment of Vibrio harveyi: a general concept of protection against bacterial infection. Res. J. Microbiol. 6(6), 560–567 (2011).
  Google Scholar
• 101. Prasad Y, Arpana, Kumar D, Sharma A. Lytic bacteriophages specific to flavobacterium columnare rescue catfish, Clarias batrachus (Linn.) from columnaris disease. J Env. Biol. 32(2), 161–168 (2011).
  MedlineGoogle Scholar
• 102. Pereira C, Moreirinha C, Lewicka M et al. Characterization and in vitro evaluation of new bacteriophages for the biocontrol of Escherichia coli. Virus Res. 227, 171–182 (2017).
  Medline CASGoogle Scholar
• 103. Duarte J, Pereira C, Moreirinha C et al. New insights on phage efficacy to control Aeromonas salmonicida in aquaculture systems: an in vitro preliminary study. Aquaculture. 495(January), 970–982 (2018).
  Google Scholar
• 104. Costa P, Pereira C, Gomes A, Almeida A. Efficiency of single phage suspensions and phage cocktail in the inactivation of Escherichia coli and Salmonella typhimurium: an in vitro preliminary study. Microorganisms 7(4), 94 (2019).
  CASGoogle Scholar
• 105. Ceyssens P–J, Miroshnikov K, Mattheus W et al. Comparative analysis of the widespread andconserved PB1-like viruses infecting Pseudomonas aeruginosa. Environ. Microbiol. 11(11), 2874–2883 (2009).
  Medline CASGoogle Scholar
• 106. Cui X, You J, Sun L et al. Characterization of Pseudomonas aeruginosa phage C11 and identification of host genes required for Virion maturation. Sci. Rep. 6(39130), 1–14 (2016).
  Medline CASGoogle Scholar
• 107. Henry M, Lavigne R, Debarbieux L. Predicting in vivo efficacy of therapeutic bacteriophages used to treat pulmonary infections. Antimicrob. Agents Chemother. 57(12), 5961–5968 (2013).
  MedlineGoogle Scholar
• 108. Henry M, Bobay L-M, Chevallereau A, Saussereau E, Ceyssens P-J, Debarbieux L. The search for therapeutic bacteriophages uncovers one new subfamily and two new genera of Pseudomonas-infecting Myoviridae. PLoS ONE 10(1), e0117163 (2015).
  MedlineGoogle Scholar
• 109. Basu A, Bobrovnikov DG, Qureshi Z et al. Measuring DNA mechanics on the genome scale. Nature 589, 462–467 (2020).
  MedlineGoogle Scholar
• 110. Basu A, Bobrovnikov DG, Cieza B, Qureshi Z, Ha T. Deciphering the mechanical code of genome and epigenome. bioRxiv. doi:https://doi.org/10.1101/2020.08.22.262352 (2020).
  Google Scholar
• 111. Wu Q, Zhou W, Wang J, Yan H. Correlation between the flexibility and periodic dinucleotide patterns in yeast nucleosomal DNA sequences. J. Theor. Biol. 284(1), 92–98 (2011).
  Medline CASGoogle Scholar
• 112. Harteis S, Schneider S. Making the bend: DNA tertiary structure and protein–DNA interactions. Int. J. Mol. Sci. 15(7), 12335–12363 (2014).
  MedlineGoogle Scholar
• 113. Mrázek J. Comparative analysis of sequence periodicity among prokaryotic genomes points to differences in nucleoid structure and a relationship to gene expression. J. Bacteriol. 192(14), 3763–3772 (2010).
  Medline CASGoogle Scholar
• 114. Yella VR, Bhimsaria D, Ghoshdastidar D, Rodríguez-Martínez JA, Ansari AZ, Bansal M. Flexibility and structure of flanking DNA impact transcription factor affinity for its core motif. Nucleic Acids Res. 46(22), 11883–11897 (2018).
  Medline CASGoogle Scholar
• 115. Jursa J, Kypr J. Propeller-twisted adenine-thymine and guanine-cytosine base pairs tend to buckle and stagger in opposite directions. Gen. Physiol. Biophys. 10, 373–381 (1991).
  Medline CASGoogle Scholar
• 116. Skewes AD, Welch RD. A Markovian analysis of bacterial genome sequence constraints. PeerJ. 1, e127 (2013).
  MedlineGoogle Scholar